Skip to main content
Log in

FHL2 antagonizes Id1-promoted proliferation and invasive capacity of human MCF-7 breast cancer cells

  • Original Article
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective

FHL2 was previously identified to be a novel interacting factor of Id family proteins. The aim of this study was to investigate, the effects of FHL2 on Id1-mediated transcriptional regulation activity and its oncogenic activity in human breast cancer cells.

Methods

Cell transfection was performed by Superfect reagent. Id1 stably overexpressed MCF-7 cells was cloned by G418 screening. The protein level of Id1 was detected by western blot analysis. Dual relative luciferase assays were used to measure the effect of E47-mediated transcriptional activity in MCF-7 human breast cancer cells. MTT assay was used to measure cell proliferation. Transwell assay was used to measure the invasive capacity of MCF-7 cancer cells.

Results

The basic helix-loop-helix (bHLH) factor E47-mediated transcription activity was markedly repressed by Id1 in MCF-7 cells. This Id1-mediated repression was effectively antagonized by FHL2 transduction. Overexpression of Id1 markedly promoted the proliferation rate and invasive capacity of MCF-7 cells; however, these effects induced by Id1 were significantly suppressed by overexpression of FHL2 in cells.

Conclusion

FHL2 can inhibit the proliferation and invasiveness of human breast cancer cells by repressing the functional activity of Id1. These findings provide the basis for further investigating the functional roles of FHL2-Id1 signaling in the carcinogenesis and development of human breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms[J]. Mol Cell Biol 2000; 20:429–440.

    Article  CAS  PubMed  Google Scholar 

  2. Norton JD, Deed RW, Craggs G, et al. Id helix-loop-helix proteins in cell growth and differentiation[J]. Trends Cell Biol 1998; 8: 58–65.

    Article  CAS  PubMed  Google Scholar 

  3. Atchley WR, Fitch WM. A natural classification of the basic helix-loop-helix class of transcription factors[J]. Proc Natl Acad Sci USA 1997; 94: 5172–5176.

    Article  CAS  PubMed  Google Scholar 

  4. Langlands K, Yin X, Anand G, et al. Differential interactions of Id proteins with basic helix- loop-helix transcription factors[J]. J Biol Chem 1997; 272:19785–19793.

    Article  CAS  PubMed  Google Scholar 

  5. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer[J]. Nat Rev Cancer 2005; 5:603–614.

    Article  CAS  PubMed  Google Scholar 

  6. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer[J]. Trends Cell Biol 2003; 13:410–418.

    Article  CAS  PubMed  Google Scholar 

  7. Lin CQ, Singh J, Murata K, et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells[J]. Cancer Res 2000; 60:1332–1340.

    CAS  PubMed  Google Scholar 

  8. Gupta GP, Perk J, Acharyya S, et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis[J]. Proc Natl Acad Sci USA 2007; 104:19506–19511.

    Article  CAS  PubMed  Google Scholar 

  9. Johannessen M, Møller S, Hansen T, et al. The multifunctional roles of the four-and-a-half-LIM only protein FHL2[J]. Cell Mol Life Sci 2006; 63:268–284.

    Article  CAS  PubMed  Google Scholar 

  10. Kleiber K, Strebhardt K, Martin BT. The biological relevance of FHL2 in tumor cells and its role as a putative cancer target[J]. Anticancer Res 2007; 27:55–61.

    CAS  PubMed  Google Scholar 

  11. Gabriel B, Fischer DC, Orlowska-Volk M, et al. Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study[J]. J Soc Gynecol Investig 2006; 13: 69–75.

    Article  CAS  PubMed  Google Scholar 

  12. Martin BT, Kleiber K, Wixler V, et al. FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells[J]. Cell Cycle 2007; 15:1779–1788.

    Article  Google Scholar 

  13. Han W, Wu Z, Zhao Y, et al. FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells[J]. Nucleic Acids Res 2009; 37:3996–4009.

    Article  CAS  PubMed  Google Scholar 

  14. Yang J, Zhao YL, Wu ZQ, et al. The single-macro domain protein LRP16 is an essential cofactor of androgen receptor[J]. Endocr Relat Cancer 2009; 16:139–153.

    Article  CAS  PubMed  Google Scholar 

  15. Meng Y, Gu C, Wu Z, et al. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors[J]. BMC Cancer 2009; 9:75.

    Article  PubMed  Google Scholar 

  16. Hendrix MJ, Seftor EA, Seftor RE, et al. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants[J]. Cancer Lett 1987; 38:137–147.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei-dong Han.

Additional information

This work was supported by the National Natural Science Foundation of China (No.30870507) and partially supported by a grant from the Ministry of Science and Technology of China (No.2010CB912802).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, Wd., Wu, Zq., Zhao, Yl. et al. FHL2 antagonizes Id1-promoted proliferation and invasive capacity of human MCF-7 breast cancer cells. Chin. J. Cancer Res. 22, 194–200 (2010). https://doi.org/10.1007/s11670-010-0194-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-010-0194-5

CLC number

Key words

Navigation